Your session is about to expire
← Back to Search
Novel Blood Drawing Apparatus for Plasma Donation
N/A
Waitlist Available
Led By Michael F Holick, MD, PhD
Research Sponsored by Boston University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
at least 18 y/o
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the time of blood analysis.
Awards & highlights
Study Summary
This trial is testing a new collection tube that could save time and cost by eliminating centrifugation steps that are currently required to obtain serum and plasma.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at the time of blood analysis.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the time of blood analysis.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of subjects with similar blood chemistry values for both blood drawing apparatuses
Trial Design
1Treatment groups
Experimental Treatment
Group I: Novel DeviceExperimental Treatment1 Intervention
Every Subject will be assigned to the same arm. This arm calls for blood to be drawn using an original blood drawing apparatus as well as using the novel blood drawing apparatus.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Novel Blood Drawing Apparatus
2016
N/A
~20
Find a Location
Who is running the clinical trial?
Boston UniversityLead Sponsor
454 Previous Clinical Trials
9,941,552 Total Patients Enrolled
Michael F Holick, MD, PhDPrincipal InvestigatorBoston University
1 Previous Clinical Trials
16 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger